A research framework for AD has recently been proposed by National Institute on Aging-Alzheimer’s Association (NIA-AA), emphasizing the importance of amyloid-β, Tau, and neuroinflammation in the pathological definition of AD (Jack et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.